These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30822499)

  • 1. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants.
    Romero-Sanchiz P; Nogueira-Arjona R; Pastor A; Araos P; Serrano A; Boronat A; Garcia-Marchena N; Mayoral F; Bordallo A; Alen F; Suárez J; de la Torre R; Pavón FJ; Rodríguez de Fonseca F
    Neuropharmacology; 2019 May; 149():212-220. PubMed ID: 30822499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence.
    Garcia-Marchena N; Pavon FJ; Pastor A; Araos P; Pedraz M; Romero-Sanchiz P; Calado M; Suarez J; Castilla-Ortega E; Orio L; Boronat A; Torrens M; Rubio G; de la Torre R; Rodriguez de Fonseca F; Serrano A
    Addict Biol; 2017 Sep; 22(5):1366-1377. PubMed ID: 27212249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
    Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
    Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.
    Jumpertz R; Wiesner T; Blüher M; Engeli S; Bátkai S; Wirtz H; Bosse-Henck A; Stumvoll M
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):591-5. PubMed ID: 20429051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
    Hill MN; Miller GE; Carrier EJ; Gorzalka BB; Hillard CJ
    Psychoneuroendocrinology; 2009 Sep; 34(8):1257-62. PubMed ID: 19394765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use.
    Kroll SL; Meier P; Mayo LM; Gertsch J; Quednow BB
    Neuropsychopharmacology; 2024 Sep; 49(10):1630-1639. PubMed ID: 38773316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
    Drummen M; Tischmann L; Gatta-Cherifi B; Cota D; Matias I; Raben A; Adam T; Westerterp-Plantenga M
    J Clin Endocrinol Metab; 2020 Jul; 105(7):e2511-20. PubMed ID: 32333763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry.
    Lam PM; Marczylo TH; Konje JC
    Anal Bioanal Chem; 2010 Nov; 398(5):2089-97. PubMed ID: 20835819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
    Smaga I; Bystrowska B; Gawliński D; Pomierny B; Stankowicz P; Filip M
    Neurotox Res; 2014 Aug; 26(2):190-206. PubMed ID: 24652522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum.
    Gebeh AK; Willets JM; Marczylo TH; Konje JC
    J Matern Fetal Neonatal Med; 2014 Jun; 27(9):954-9. PubMed ID: 24117326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of norepinephrine and serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models of behavior despair.
    Yu HL; Sun LP; Li MM; Quan ZS
    Neurosci Lett; 2015 Apr; 593():24-8. PubMed ID: 25778418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.
    Couttas TA; Boost C; Pahlisch F; Sykorova EB; Mueller JK; Jieu B; Leweke JE; Dammann I; Hoffmann AE; Loeffler M; Grimm O; Enning F; Flor H; Meyer-Lindenberg A; Koethe D; Rohleder C; Leweke FM
    BMJ Ment Health; 2024 Aug; 27(1):. PubMed ID: 39182921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
    Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients.
    Herrera-Imbroda J; Flores-López M; Requena-Ocaña N; Araos P; García-Marchena N; Ropero J; Bordallo A; Suarez J; Pavón-Morón FJ; Serrano A; Mayoral F; Rodríguez de Fonseca F
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa.
    Monteleone AM; Di Marzo V; Aveta T; Piscitelli F; Dalle Grave R; Scognamiglio P; El Ghoch M; Calugi S; Monteleone P; Maj M
    Am J Clin Nutr; 2015 Feb; 101(2):262-9. PubMed ID: 25646322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
    Ho WS; Barrett DA; Randall MD
    Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer.
    Grill M; Högenauer C; Blesl A; Haybaeck J; Golob-Schwarzl N; Ferreirós N; Thomas D; Gurke R; Trötzmüller M; Köfeler HC; Gallé B; Schicho R
    Sci Rep; 2019 Feb; 9(1):2358. PubMed ID: 30787385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.